Skip to main content
Top
Published in: Tobacco Induced Diseases 1/2015

Open Access 01-12-2015 | Research

No difference in hypertension prevalence in smokers, former smokers and non-smokers after adjusting for body mass index and age: a cross-sectional study from the Czech Republic, 2010

Authors: Alexandra Pankova, Eva Kralikova, Keely Fraser, Jan Lajka, Stepan Svacina, Martin Matoulek

Published in: Tobacco Induced Diseases | Issue 1/2015

Login to get access

Abstract

Background

Several hypotheses suggest a temporary increase in blood pressure following smoking cessation. This may be the result of endocrine changes (e.g. alteration in adrenocorticotropic hormone and cortisol levels in post-cessation period) and/or post-cessation weight gain. Our aim was to identify factors that may be associated with the diagnosis of hypertension after quitting smoking.

Methods

In 2010, we conducted a cross-sectional survey in a sample of 2065 Czech adults, chosen by quota selection and representative according to age, gender, education, region of residence and the size of settlement, aged 18 to 94 years. We examined the association between age, gender, body mass index, smoking status, and education with the hypertension diagnosis in their personal history. Data were compiled and weighed by age categories. Statistical significance was measured by Pearson Chi-square test at the level of significance 95 %.

Results

Diagnosis of hypertension was reported in 461 (22 %) subjects, with no difference by gender. Based on univariate analysis, former smokers were more likely than non-smokers to be diagnosed for hypertension (OR 1.450 (1.110-1.900), p = 0.006). However, after adjusting for body mass index and age, the occurrence of hypertension diagnosis did not differ among non-smokers, smokers and former smokers (OR 0.760 for smokers, p = 0.082 and OR 1.020 for former smokers, p = 0.915).

Conclusion

We did not find any differences in hypertension diagnosis prevalence according to smoking status.
Literature
3.
go back to reference Duskova M, Simunkova K, Hill M, Velikova A, Kubatova J, Kancheva L, et al. Chronic cigarette smoking alters circulating Sex hormones and neuroactive steroids in premenopausal women. Physiol Res. 2012;61:97–111.PubMed Duskova M, Simunkova K, Hill M, Velikova A, Kubatova J, Kancheva L, et al. Chronic cigarette smoking alters circulating Sex hormones and neuroactive steroids in premenopausal women. Physiol Res. 2012;61:97–111.PubMed
4.
go back to reference Starka L, Hill M, Kralikova E. Smoking and endocrine system. (in Czech). Diabetologie Metabolismus Endokrinologie Vyziva. 2005;8:180–6. Starka L, Hill M, Kralikova E. Smoking and endocrine system. (in Czech). Diabetologie Metabolismus Endokrinologie Vyziva. 2005;8:180–6.
5.
go back to reference Baer L, Radichevich I. Cigarette smoking in hypertensive patients. Blood pressure and endocrine responses. Am J Med. 1985;78:564–8.PubMedCrossRef Baer L, Radichevich I. Cigarette smoking in hypertensive patients. Blood pressure and endocrine responses. Am J Med. 1985;78:564–8.PubMedCrossRef
6.
go back to reference Lang NN, Gudmundsdottir IJ, Boon NA, Ludlam CA, Fox KA, Newby DE. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo. J Am Coll Cardiol. 2008;52:33–9.PubMedCrossRef Lang NN, Gudmundsdottir IJ, Boon NA, Ludlam CA, Fox KA, Newby DE. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo. J Am Coll Cardiol. 2008;52:33–9.PubMedCrossRef
7.
go back to reference Mahmud A, Feely J. Effects of smoking on arterial stiffness and pulse pressure amplification. Hypertension. 2003;41:183–7.PubMedCrossRef Mahmud A, Feely J. Effects of smoking on arterial stiffness and pulse pressure amplification. Hypertension. 2003;41:183–7.PubMedCrossRef
8.
go back to reference Howard G, Burke GL, Szklo M, Tell GS, Eckfeldt J, Evans G, et al. Active and passive smoking are associated with increased carotid artery wall thickness: the atherosclerosis risk in communities study. Arch Intern Med. 1994;154:1277–82.PubMedCrossRef Howard G, Burke GL, Szklo M, Tell GS, Eckfeldt J, Evans G, et al. Active and passive smoking are associated with increased carotid artery wall thickness: the atherosclerosis risk in communities study. Arch Intern Med. 1994;154:1277–82.PubMedCrossRef
9.
go back to reference Green MS, Jucha E, Luz Y. Blood pressure in smokers and non-smokers: epidemiologic findings. Am Heart J. 1986;111:932–40.PubMedCrossRef Green MS, Jucha E, Luz Y. Blood pressure in smokers and non-smokers: epidemiologic findings. Am Heart J. 1986;111:932–40.PubMedCrossRef
10.
go back to reference Mann SJ, James GD, Wang RS, Pickering TG. Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. JAMA. 1991;265:2226–8.PubMedCrossRef Mann SJ, James GD, Wang RS, Pickering TG. Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. JAMA. 1991;265:2226–8.PubMedCrossRef
11.
go back to reference Narkiewicz K, Maraglino G, Biasion T, Rossi G, Sanzuol F, Palatini P. Interactive effect of cigarettes and coffee on daytime systolic blood pressure in patients with mild essential hypertension. HARVEST Study Group (Italy). Hypertension Ambulatory Recording VEnetia STudy. J Hypertens. 1995;13:965–70.PubMedCrossRef Narkiewicz K, Maraglino G, Biasion T, Rossi G, Sanzuol F, Palatini P. Interactive effect of cigarettes and coffee on daytime systolic blood pressure in patients with mild essential hypertension. HARVEST Study Group (Italy). Hypertension Ambulatory Recording VEnetia STudy. J Hypertens. 1995;13:965–70.PubMedCrossRef
12.
go back to reference Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Battistelli M, et al. Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension. J Hypertens. 1995;13:1209–15.PubMedCrossRef Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Battistelli M, et al. Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension. J Hypertens. 1995;13:1209–15.PubMedCrossRef
14.
go back to reference Savdie E, Grosslight GM, Adena MA. Relation of alcohol and cigarette consumption to blood pressure and serum creatinine levels. J Chron Dis. 1984;37:617–23.PubMedCrossRef Savdie E, Grosslight GM, Adena MA. Relation of alcohol and cigarette consumption to blood pressure and serum creatinine levels. J Chron Dis. 1984;37:617–23.PubMedCrossRef
15.
go back to reference Halimi JM, Giradeau B, Vol S, Caces E, Nivet H, Tichet J. The risk of hypertension in men: direct and indirect effects of chronic smoking. J Hypertens. 2002;20:187–93.PubMedCrossRef Halimi JM, Giradeau B, Vol S, Caces E, Nivet H, Tichet J. The risk of hypertension in men: direct and indirect effects of chronic smoking. J Hypertens. 2002;20:187–93.PubMedCrossRef
16.
go back to reference Onat A, Ugur M, Hergenc G, Can G, Ordu S, Dursunoglu D. Lifestyle and metabolic determinants of incident hypertension, with special reference to cigarette smoking: a longitudinal population-based study. Am J Hypertens. 2009;22:156–62.PubMedCrossRef Onat A, Ugur M, Hergenc G, Can G, Ordu S, Dursunoglu D. Lifestyle and metabolic determinants of incident hypertension, with special reference to cigarette smoking: a longitudinal population-based study. Am J Hypertens. 2009;22:156–62.PubMedCrossRef
17.
go back to reference Jazon E, Hedblad B, Berglund G, Engstrom G. Changes in blood pressure and body weight following smoking cessation in women. J Intern Med. 2004;255:266–72.CrossRef Jazon E, Hedblad B, Berglund G, Engstrom G. Changes in blood pressure and body weight following smoking cessation in women. J Intern Med. 2004;255:266–72.CrossRef
18.
go back to reference Gordon T, Kannel WB, Dawber TR, McGee D. Changes associated with quitting cigarette smoking: the Framingham study. Am Heart J. 1975;90:322–8.PubMedCrossRef Gordon T, Kannel WB, Dawber TR, McGee D. Changes associated with quitting cigarette smoking: the Framingham study. Am Heart J. 1975;90:322–8.PubMedCrossRef
19.
go back to reference Green MS, Harari G. A prospective study of the effects of changes in smoking habits on blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men. J Clin Epidemiol. 1995;48:1159–66.PubMedCrossRef Green MS, Harari G. A prospective study of the effects of changes in smoking habits on blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men. J Clin Epidemiol. 1995;48:1159–66.PubMedCrossRef
20.
go back to reference Oren S, Isakov I, Golzman B, Kogan J, Turkot S, Peled R, et al. The influence of smoking cessation on hemodynamics and arterial compliance. Angiology. 2006;57:564–8.PubMedCrossRef Oren S, Isakov I, Golzman B, Kogan J, Turkot S, Peled R, et al. The influence of smoking cessation on hemodynamics and arterial compliance. Angiology. 2006;57:564–8.PubMedCrossRef
21.
go back to reference Polónia J, Barbosa L, Silva JA, Rosas M. Improvement of aortic reflection wave responses 6 months after stopping smoking: a prospective study. Blood Press Monit. 2009;14:69–75.PubMedCrossRef Polónia J, Barbosa L, Silva JA, Rosas M. Improvement of aortic reflection wave responses 6 months after stopping smoking: a prospective study. Blood Press Monit. 2009;14:69–75.PubMedCrossRef
22.
go back to reference Lee DH, Ha MH, Kim JR, Jacobs Jr DR. Effects of smoking cessation on changes in blood pressure and incidence of hypertension: a 4-year follow-up study. Hypertension. 2001;37:194–8.PubMedCrossRef Lee DH, Ha MH, Kim JR, Jacobs Jr DR. Effects of smoking cessation on changes in blood pressure and incidence of hypertension: a 4-year follow-up study. Hypertension. 2001;37:194–8.PubMedCrossRef
24.
go back to reference Kunes J, Kadlecova M, Vaneckova I, Zicha J. Critical developmental periods in the pathogenesis of hypertension. Physiol Res. 2012;61 Suppl 1:9–17. Kunes J, Kadlecova M, Vaneckova I, Zicha J. Critical developmental periods in the pathogenesis of hypertension. Physiol Res. 2012;61 Suppl 1:9–17.
26.
go back to reference Yoshida T, Yoshioka K, Hiraoka N, Kondo M. Effect of nicotine on norepinephrine turnover and thermogenesis in brown adipose tissue and metabolic rate in MSG obese mice. J Nutr Sci Vitaminol. 1990;36:123–30.PubMedCrossRef Yoshida T, Yoshioka K, Hiraoka N, Kondo M. Effect of nicotine on norepinephrine turnover and thermogenesis in brown adipose tissue and metabolic rate in MSG obese mice. J Nutr Sci Vitaminol. 1990;36:123–30.PubMedCrossRef
27.
go back to reference Hofstetter A, Schutz Y, Jequier E, Wahren K. Increased 24-hour energy expenditure in cigarette smokers. N Eng J Med. 1986;314:79–82.CrossRef Hofstetter A, Schutz Y, Jequier E, Wahren K. Increased 24-hour energy expenditure in cigarette smokers. N Eng J Med. 1986;314:79–82.CrossRef
28.
go back to reference Chatkin R, Chatkin JM. Smoking and changes in body weight: can physiopathology and genetics explain this association? J Bras Pneumol. 2007;33:712–9.PubMedCrossRef Chatkin R, Chatkin JM. Smoking and changes in body weight: can physiopathology and genetics explain this association? J Bras Pneumol. 2007;33:712–9.PubMedCrossRef
29.
go back to reference Mineur YS, Abizaid A, Rao Y, Salas R, Dileone RJ, Gundisch D, et al. Nicotine decreases food intake through activation of POMC neurons. Science. 2011;332:1330–2.PubMedCentralPubMedCrossRef Mineur YS, Abizaid A, Rao Y, Salas R, Dileone RJ, Gundisch D, et al. Nicotine decreases food intake through activation of POMC neurons. Science. 2011;332:1330–2.PubMedCentralPubMedCrossRef
30.
go back to reference Pomerleau OF, Pomerleau CS, Snedecor SM, Gaulrapp S, Brouwer RN, Cameron OG. Depression, smoking abstinence and HPA function in women smokers. Hum Psychopharmacol. 2002;19:467–76.CrossRef Pomerleau OF, Pomerleau CS, Snedecor SM, Gaulrapp S, Brouwer RN, Cameron OG. Depression, smoking abstinence and HPA function in women smokers. Hum Psychopharmacol. 2002;19:467–76.CrossRef
31.
go back to reference Nowak J, Murray JJ, Oates JA, Fitzgerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation. 1987;76:6–14.PubMedCrossRef Nowak J, Murray JJ, Oates JA, Fitzgerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation. 1987;76:6–14.PubMedCrossRef
32.
go back to reference Stefanidis C, Tsiamis E, Vlachopoulos C, Stratos C, Toutouzas K, Pitsavos C, et al. Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation. 1997;95:31–8.CrossRef Stefanidis C, Tsiamis E, Vlachopoulos C, Stratos C, Toutouzas K, Pitsavos C, et al. Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation. 1997;95:31–8.CrossRef
33.
go back to reference Jatoi NA, Jerrard-Dunne P, Feely J, Mahmud A. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension. 2007;49:981–5.PubMedCrossRef Jatoi NA, Jerrard-Dunne P, Feely J, Mahmud A. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension. 2007;49:981–5.PubMedCrossRef
34.
go back to reference Kearns K, Dee A, Fitzgerald AP, Doherty E, Perry IJ. Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level. BMC Public Health. 2014;14:143.PubMedCentralPubMedCrossRef Kearns K, Dee A, Fitzgerald AP, Doherty E, Perry IJ. Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level. BMC Public Health. 2014;14:143.PubMedCentralPubMedCrossRef
36.
go back to reference Peixoto SV, Firmo JO, Lima-Costa MF. Factors associated with smoking cessation in two different populations (Bambuí and Belo Horizonte Projects). Cad Saude Publica 207. 23:1319–28. Peixoto SV, Firmo JO, Lima-Costa MF. Factors associated with smoking cessation in two different populations (Bambuí and Belo Horizonte Projects). Cad Saude Publica 207. 23:1319–28.
37.
go back to reference Albanes D, Jones DY, Micozzi MS, Mattson ME. Associations between smoking and body weight in the U.S. population: analysis of NHANES II. Am J Public Health. 1987;77:439–44.PubMedCentralPubMedCrossRef Albanes D, Jones DY, Micozzi MS, Mattson ME. Associations between smoking and body weight in the U.S. population: analysis of NHANES II. Am J Public Health. 1987;77:439–44.PubMedCentralPubMedCrossRef
38.
go back to reference Molarius A, Seidell JC, Kuulasmaa K, Dobson AJ, Sans S. Smoking and relative body weight: an international perspective from the WHO MONICA Project. J Epidemiol Community Health. 1997;51:252–60.PubMedCentralPubMedCrossRef Molarius A, Seidell JC, Kuulasmaa K, Dobson AJ, Sans S. Smoking and relative body weight: an international perspective from the WHO MONICA Project. J Epidemiol Community Health. 1997;51:252–60.PubMedCentralPubMedCrossRef
40.
go back to reference Noppa H, Bengtsson C. Obesity in relation to smoking: a population study of women in Göteborg, Sweden. Prev Med. 1980;9:534–43.PubMedCrossRef Noppa H, Bengtsson C. Obesity in relation to smoking: a population study of women in Göteborg, Sweden. Prev Med. 1980;9:534–43.PubMedCrossRef
42.
go back to reference Cifkova R, Bruthans J, Adamkova V, Jozifova M, Galovcova M, Wolfhart P, et al. The prevalence of major cardiovascular risk factors in the Czech population in 2006–2009. The Czech post-MONICA study. Cor Vasa. 2011;53:220–9. Cifkova R, Bruthans J, Adamkova V, Jozifova M, Galovcova M, Wolfhart P, et al. The prevalence of major cardiovascular risk factors in the Czech population in 2006–2009. The Czech post-MONICA study. Cor Vasa. 2011;53:220–9.
Metadata
Title
No difference in hypertension prevalence in smokers, former smokers and non-smokers after adjusting for body mass index and age: a cross-sectional study from the Czech Republic, 2010
Authors
Alexandra Pankova
Eva Kralikova
Keely Fraser
Jan Lajka
Stepan Svacina
Martin Matoulek
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2015
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/s12971-015-0049-4

Other articles of this Issue 1/2015

Tobacco Induced Diseases 1/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.